|
|
|
|
A pharma company was in the process of tech transferring a powder-filled capsule program to a CDMO when transfer batches showed poor content uniformity. Learn how to overcome tech transfer challenges and ensure consistent content uniformity by utilizing multidisciplinary expertise and decades of commercial encapsulation experience.
|
|
|
|
|
Limited solubility can lead to formulations with inadequate oral bioavailability. Discover how modifying the micro-environment with targeted excipients can significantly enhance the dissolution rate of poorly soluble drugs using conventional manufacturing methods.
|
|
|
|
|
Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering. The value-add of a CDMO functioning on this level of partnership stretches far beyond what is expected in the manufacturing suite.
|
|
|
|
|
A pharma company conducted a risk assessment for potential natural disasters and shipping constraints in their supply chain. Explore how strategic U.S.-based manufacturing and supply chain diversification can reduce risk, lower costs, and enhance supply reliability.
|
|
|
|
OUTSOURCED PHARMA CAPACITY UPDATE VIDEO FEATURE
|
|
|
|
|
Find expert small molecule solutions with specialized capabilities in large-scale oral solid dosage, advanced formulations, controlled substances, and high-potency compounds
|
|
|
